Table 3.
Drop-outs from the study
| Reason for drop-outs | Group |
Total | |
|---|---|---|---|
| A | B | ||
| No improvement (%) | 3 (8.6%) | 0 (0%) | 3 (1.5%) |
| Side effects (%) | 1 (2.9%) | 2 (6.1%) | 3 (2.3%) |
| Worsening of lesions (%) | 2 (5.7%) | 0 (0%) | 2 (0.8%) |
| Loss to follow-up (%) | 0 (0%) | 1 (3.0%) | 1 (1.5%) |
| Total (%) | 35 (100.0%) | 33 (100.0%) | 68 (100.0%) |